Related Experiment Video
Updated: Jul 16, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Immune regulation of human colonic electrolyte transport in vitro
W A Stack1, S J Keely, D P O'Donoghue
1Department of Pharmacology, University College Dublin, Ireland.
Insights
Immune cells in the colon regulate ion transport, stimulating chloride secretion. This process may cause secretory diarrhea, potentially protecting against parasites or indicating bowel inflammation.
Area of Science:
- Gastroenterology
- Immunology
- Physiology
Background:
- The lamina propria contains immune cells that can influence colonic function.
- Understanding immune cell roles in ion transport is crucial for gastrointestinal health.
Purpose of the Study:
- To investigate the role of lamina propria cells in regulating human colonic ion transport.
- To identify mediators involved in immune cell-stimulated ion transport.
Main Methods:
- Human colonic mucosa mounted in Ussing chambers to measure short-circuit current (SCC).
- Stimulation of mast cells with anti-human immunoglobulin E (anti-IgE) and phagocytes with formyl-Methionyl-Leucyl-Phenylalanine (fMLP).
- Pharmacological agents (bumetanide, piroxicam, mepyramine) used to identify ion species and mediators.
Main Results:
- Anti-IgE and fMLP induced rapid inward short-circuit current changes, indicating ion transport.
- Responses were attenuated by bumetanide, suggesting electrogenic chloride secretion.
- Piroxicam implicated eicosanoids, while mepyramine indicated histamine's role in anti-IgE responses.
Conclusions:
- Activation of colonic immune cells stimulates electrogenic chloride secretion.
- This mechanism may lead to secretory diarrhea in vivo.
- Such responses could be protective against parasites or indicative of inflammatory bowel disease.
Abstract:
The role of lamina propria cells in regulating human colonic ion transport was investigated in vitro. Normal human colonic mucosae were mounted in Ussing chambers, and short circuit current changes (delta SCC) were monitored in response to immune cell activation. Anti-human immunoglobulin E (anti-IgE) and formyl-Methionyl-Leucyl-Phenylalanine (fMLP) were used to stimulate mast cells and phagocytes respectively. Anti-IgE (100 micrograms/ml) and fMLP (100 microM) evoked rapid onset, inward delta SCC (mean (SEM) max delta SCC 19.3 (2.8) and 29.4 (4.7) microA/0.63 cm2 respectively). A pharmacological approach was used to identify the charge carrying ion species and to characterise mediators involved in the SCC response. Responses to each secretagogue were significantly attenuated by bumetanide, indicating that the delta SCC was at least partly due to electrogenic chloride secretion. Piroxicam reduced the delta SCC to mast cell and phagocyte activation by 91.1 (3.4)% and 48.2 (25.2)% respectively, implicating eicosanoids as mediators of the responses. Mepyramine (100 microM) reduced the SCC responses to anti-IgE by 79.6 (12.0)% but did not significantly alter delta SCC responses to fMLP. Desensitisation to repeated anti-IgE or fMLP stimulation, and cross desensitisation between each of the stimuli, were features of immune cell activation. In summary, we have shown that activation of immune cells can stimulate electrogenic chloride secretion. Such events in vivo will result in gradient driven secretory diarrhoea, which may occur as a protective response to enteric-dwelling parasites, or as a feature of local bowel inflammation.

